X
Record #21103

HDAC6 inhibitor TST strengthens the antiproliferative effects of PI3K/mTOR inhibitor BEZ235 in breast cancer cells via suppressing RTK activation

Original paper date
Sep 11, 2018
Institution
Department of Physiology, Nanjing Medical University, Nanjing, Jiangsu, 211166, China · Key Laboratory of Cardiovascular & Cerebrovascular Medicine, School of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu, 211166, China · Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center For Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu, 211166, China · BGI Education Center, University of Chinese Academy of Sciences, Shenzhen, Guangdong, 518083, China · Department of Physiology, Xuzhou Medical University, Xuzhou, Jiangsu, 221004, China · Department of Biochemistry and Molecular Biology, Nanjing Medical University, Nanjing, Jiangsu, 211166, China · Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210029, China · Department of Physiology, School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, 212013, China
Open access
No
Article type
Research Article
Broad categories
(BLS) Biochemistry(BLS) Biology - Cancer(BLS) Biology - Cellular(HSC) Medicine - Obstetrics/Gynecology(HSC) Medicine - Oncology
Citation lifecycle

How this paper is being cited

Pre-retraction
1
Same day
0
Post-retraction
10
% post-retraction
100.0%
~1.1 citations/yr before retraction · ~1.4 citations/yr after
— citing papers

Who is still citing this work

Loading…
Back to browse